CFBICentre for Business Innovation (UK)
CFBICenter for Functional Brain Imaging
CFBIColorado Farm Bureau Insurance (Centennial, CO)
CFBICertified Florida Business Intermediary (Florida Business Brokers Association)
CFBIClayton Foundation Biochemical Institute (University of Texas)
CFBICalifornia Family Business Institute, LLC
Copyright 1988-2018, All rights reserved.
References in periodicals archive ?
(NYSE American: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction.
The merger will expand CFBI's presence in the Atlanta MSA and accelerate CFBI's growth strategy following its mutual holding company reorganisation and initial public offering in 2017.
Upon completion of the transaction, Ed Cooney will become chief executive officer of CFBI and Newton Federal Bank and a director of both; Johnny Smith of CFBI will remain president of CFBI and the bank and will continue to serve on the both boards; Affinity Bank will merge into Newton Federal Bank and as per the 30 June 2019 bank-level financials and excluding merger accounting adjustments, the combined institution will have assets of about USD613m, USD465m in deposits and USD500m in loans.
Gender, age, duration of work, use of protective glasses, and the health insurance status of the study metal workers with CFBI were recorded.
19 June 2015 - Israeli biotechnology company Can-Fite BioPharma Ltd.'s (NYSE: CANF) (TASE: CFBI) OphthaliX (OTCQB: OPLI) subsidiary has signed a definitive agreement to acquire Israeli medical device maker Improved Vision Systems Ltd., the company said.
(NYSE American: CANF) (TASE: CFBI) has expanded its distribution agreement with Chong Kun Dang Pharmaceuticals (Korean Stock Exchange: 185750.KS) in South Korea, for the indication of non-alcoholic steatohepatitis, the company said.
(NYSE American: CANF) (TASE: CFBI) has received a Notice of Allowance from the US Patent and Trademark Office for its patent application titled, "Use of A3 adenosine receptor agonist in the treatment of Osteoarthritis," the company said.
(CFBI) of Harrison, Arkansas, and the merger of Community First Bank with and into Equity Bank, as per the definitive agreement announced on July 2016, effective November 10, 2016.
(NYSE American: CANF) (TASE: CFBI) has signed a License, Collaboration and Distribution Agreement with CMS Medical Venture Investment Ltd.
Can-Fite BioPharma (NYSE MKT: CANF) (CFBI.TA ), a biotechnology company, has received fast track designation for its CF102 drug candidate from the US Food and Drug Administration, it was announced on Friday.